One Class of Antidiabetic Linked With Lower Kidney Stone Risk

(MedPage Today) -- One class of glucose-lowering agent may help lower the risk of kidney stones in adults with type 2 diabetes, a cohort study suggested. Adults who newly started on an SGLT2 inhibitor had a 31% lower risk of nephrolithiasis compared...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news